BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21719748)

  • 1. EBM-based Clinical Guidelines for Pancreatic Cancer 2009 from the Japan Pancreas Society: a synopsis.
    Yamaguchi K; Tanaka M;
    Jpn J Clin Oncol; 2011 Jul; 41(7):836-40. PubMed ID: 21719748
    [No Abstract]   [Full Text] [Related]  

  • 2. EBM-based Clinical Guidelines for Pancreatic Cancer (2013) issued by the Japan Pancreas Society: a synopsis.
    Yamaguchi K; Okusaka T; Shimizu K; Furuse J; Ito Y; Hanada K; Shimosegawa T;
    Jpn J Clin Oncol; 2014 Oct; 44(10):883-8. PubMed ID: 25205672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidental pancreatic tumors: diagnosis and management].
    Hammel P
    Gastroenterol Clin Biol; 2002; 26(8-9):700-8. PubMed ID: 12434071
    [No Abstract]   [Full Text] [Related]  

  • 4. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
    Janson ET; Sørbye H; Welin S; Federspiel B; Grønbaek H; Hellman P; Mathisen O; Mortensen J; Sundin A; Thiis-Evensen E; Välimäki MJ; Oberg K; Knigge U
    Acta Oncol; 2010 Aug; 49(6):740-56. PubMed ID: 20553100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of pancreatic cancer.
    Yeo CJ; Cameron JL
    Ann Chir Gynaecol; 2000; 89(3):225-33. PubMed ID: 11079793
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dismal scenario in pancreatic carcinoma: is there any hope at all?].
    Stiefelhagen P
    MMW Fortschr Med; 2004 Apr; 146(16):4-6, 8. PubMed ID: 15222491
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant therapy for pancreatic cancer: current status and future directions.
    Xiong HQ; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic adenocarcinoma.
    Eskander MF; Bliss LA; Tseng JF
    Curr Probl Surg; 2016 Mar; 53(3):107-54. PubMed ID: 26923296
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selection of methods for diagnosis and treatment of pancreatic cancer].
    Ozaki H; Kinoshita T; Kosuge T; Shimada K; Yamamoto J; Inoue K
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2311-8. PubMed ID: 1463336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality management of localized pancreatic cancer.
    Wayne JD; Wolff RA; Pisters PW; Evans DB
    Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Virginia Mason approach to localized pancreatic cancer.
    Picozzi VJ; Traverso LW
    Surg Oncol Clin N Am; 2004 Oct; 13(4):663-74, ix. PubMed ID: 15350940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemoradiotherapy including intraoperative radiotherapy for advanced and relapsed pancreatic tumors].
    Matsumoto G; Tsuruta K; Okamoto A; Karasawa K; Kamata N
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():243-7. PubMed ID: 16457259
    [No Abstract]   [Full Text] [Related]  

  • 13. The diagnosis of pancreatic cancer.
    Brand R
    Cancer J; 2001; 7(4):287-97. PubMed ID: 11561605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of pancreatic cancer.
    De La Cruz MS; Young AP; Ruffin MT
    Am Fam Physician; 2014 Apr; 89(8):626-32. PubMed ID: 24784121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Burkitt's lymphoma of the pancreas].
    Petit R; Pein F; Calès P; Bouin E; Cerez H; Boyer J
    Gastroenterol Clin Biol; 1992; 16(1):99-100. PubMed ID: 1347026
    [No Abstract]   [Full Text] [Related]  

  • 17. Status of neoadjuvant therapy for resectable pancreatic cancer.
    Hoffman JP
    Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
    Pisters PW; Evans DB
    Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
    [No Abstract]   [Full Text] [Related]  

  • 19. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.
    Stojadinovic A; Brooks A; Hoos A; Jaques DP; Conlon KC; Brennan MF
    J Am Coll Surg; 2003 Jun; 196(6):954-64. PubMed ID: 12788434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pancreatic mass in a patient with nausea and vomiting. Extrapulmonary small cell carcinoma of the pancreas.
    Choi EH; Coyle W
    Gastroenterology; 2011 Mar; 140(3):e5-6. PubMed ID: 21276764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.